Aplastic Anemia in a Patient with Cronkhite-Canada Syndrome

Intern Med. 2021;60(10):1601-1605. doi: 10.2169/internalmedicine.6468-20. Epub 2021 May 15.

Abstract

Cronkhite-Canada syndrome (CCS) is a rare polyposis disorder accompanied by alopecia and onychodystrophy. A 63-year-old man with a history of CCS and repeated embolism developed progressive thrombocytopenia and mild anemia. Laboratory testing, a bone marrow examination, and magnetic resonance imaging of the spine resulted in a diagnosis of concurrent aplastic anemia (AA). Paroxysmal nocturnal hemoglobinuria (PNH)-type cells were detected in a peripheral blood specimen. In addition, human leukocyte antigen (HLA) included DRB1*15:01 and DRB1*15:02. Mesalazine was discontinued in consideration of possible drug-induced pancytopenia. Immunosuppressive therapy ameliorated both the gastrointestinal symptoms of CCS and pancytopenia. A common autoimmune abnormality might underlie both CCS and AA.

Keywords: Cronkhite-Canada syndrome; aplastic anemia; autoimmune disorder; human leukocyte antigen; paroxysmal nocturnal hemoglobinuria.

Publication types

  • Case Reports

MeSH terms

  • Anemia, Aplastic* / complications
  • Anemia, Aplastic* / diagnosis
  • Hemoglobinuria, Paroxysmal* / complications
  • Hemoglobinuria, Paroxysmal* / diagnosis
  • Histocompatibility Antigens Class I
  • Humans
  • Intestinal Polyposis* / complications
  • Intestinal Polyposis* / diagnosis
  • Male
  • Mesalamine
  • Middle Aged

Substances

  • Histocompatibility Antigens Class I
  • Mesalamine